News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,234 Results
Type
Article (13619)
Company Profile (109)
Press Release (248506)
Section
Business (88002)
Career Advice (464)
Deals (15336)
Drug Delivery (64)
Drug Development (36574)
Employer Resources (49)
FDA (6270)
Job Trends (6188)
News (150143)
Policy (14018)
Tag
Academia (436)
Alliances (23138)
Alzheimer's disease (362)
Approvals (6276)
Artificial intelligence (66)
Bankruptcy (143)
Best Places to Work (4349)
Biotechnology (44)
Breast cancer (60)
Cancer (399)
Career advice (406)
Cell therapy (56)
Clinical research (30578)
Collaboration (194)
Compensation (79)
COVID-19 (749)
C-suite (58)
Data (425)
Diabetes (59)
Diagnostics (1244)
Drug pricing (59)
Earnings (31605)
Employer resources (43)
Events (36911)
Executive appointments (217)
FDA (6494)
Funding (128)
Gene therapy (62)
GLP-1 (301)
Government (1271)
Healthcare (3545)
Infectious disease (769)
Inflammatory bowel disease (49)
Interviews (58)
IPO (5838)
Job creations (2050)
Job search strategy (372)
Layoffs (168)
Legal (3415)
Lung cancer (55)
Manufacturing (110)
Medical device (1270)
Medtech (1272)
Mergers & acquisitions (9566)
Metabolic disorders (185)
Neuroscience (473)
NextGen Class of 2024 (1584)
Non-profit (592)
Northern California (490)
Obesity (109)
Opinion (111)
Patents (63)
People (28556)
Pharmaceutical (67)
Phase I (7953)
Phase II (12931)
Phase III (11623)
Pipeline (198)
Policy (46)
Postmarket research (1400)
Preclinical (3180)
Radiopharmaceuticals (116)
Rare diseases (105)
Real estate (2636)
Regulatory (9881)
Research institute (564)
Resumes & cover letters (55)
Southern California (489)
Startups (1627)
United States (4832)
Vaccines (114)
Weight loss (81)
Date
Today (6)
Last 7 days (222)
Last 30 days (814)
Last 365 days (12488)
2024 (12428)
2023 (14262)
2022 (19576)
2021 (20099)
2020 (19058)
2019 (14910)
2018 (11725)
2017 (13893)
2016 (13134)
2015 (15477)
2014 (12421)
2013 (10594)
2012 (11398)
2011 (11926)
2010 (10891)
Location
Africa (312)
Arizona (43)
Asia (19873)
Australia (2565)
California (1153)
Canada (670)
China (137)
Colorado (46)
Connecticut (52)
Europe (38918)
Florida (180)
Illinois (133)
Indiana (95)
Japan (51)
Kansas (51)
Maryland (171)
Massachusetts (986)
Minnesota (65)
New Jersey (494)
New York (322)
North Carolina (292)
Northern California (490)
Pennsylvania (312)
South America (498)
Southern California (489)
Texas (158)
Virginia (45)
Washington State (78)
262,234 Results for "serenity pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Beltone Unveils a New Generation of Hearing Solutions with Beltone Serene
Beltone, named one of America’s Best Retailers and Customer Service for Hearing Care by Newsweek, announced its latest innovation in hearing care – the new Beltone Serene™ hearing aid.
September 28, 2023
·
4 min read
Press Releases
BioXcel Therapeutics Announces Initiation of SERENITY At-Home Pivotal Phase 3 Safety Trial of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
September 5, 2024
·
9 min read
Business
Acerus Announces Amendment to Promissory Note Due to Former Serenity Shareholders
Acerus Pharmaceuticals Corporation today announced that it has amended the promissory note (the “ Note ”) in the amount of US$4.91 million related to the up-front fee owed to former Serenity Pharmaceuticals LLC (“Serenity”) securityholders.
October 3, 2022
·
3 min read
Biotech Beach
Quantgene Launches Serenity Complete, the Next Generation Executive Physical
Quantgene, a Santa Monica, CA-based biotechnology, cloud and AI company, that focuses on precision medicine, introduced Serenity Complete, a new preventive health tool developed to help attract and retain top-tier talent.
November 14, 2022
·
5 min read
Business
Acerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity Securityholders
Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX:ASP; OTCQB:ASPCD) today announced that it has entered into an amended and restated promissory note (the “ A&R Note ”) covering the up-front fee owed to former Serenity Pharmaceuticals LLC (“ Serenity ”) securityholders.
June 7, 2022
·
2 min read
Business
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
BioXcel Therapeutics, Inc. provided an update on its late-stage TRANQUILITY and SERENITY clinical programs.
March 12, 2024
·
18 min read
Deals
Acerus Announces Definitive Agreement to Acquire Serenity LLC and the Global Rights to Noctiva™
Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it has entered into a definitive agreement (the “Definitive Agreement”) to indirectly acquire Serenity LLC (“Serenity”) and the global rights to its Noctiva brand in a combined cash and stock transaction.
February 28, 2022
·
15 min read
Deals
Serenity Bioworks Acquires DC-TAB for Lupus Nephritis
Serenity Bioworks announces today it has completed the acquisition of DC-TAB, a recombinant human HspB5 that was previously in clinical development for relapse-remitting multiple sclerosis.
April 27, 2022
·
2 min read
Deals
Acerus Announces Closing of Acquisition of Serenity Pharmaceuticals LLC and Acquisition of Global Rights to Noctiva™Conference Call to be Held on March 9, 2022 at 8:30am ET to Discuss Transaction
Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced the closing of its previously-announced acquisition of Serenity Pharmaceuticals LLC (“Serenity”), including the global rights to its Noctiva™ brand.
March 7, 2022
·
6 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
1 of 26,224
Next
